...
首页> 外文期刊>Current molecular medicine >FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype.
【24h】

FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype.

机译:FOXP3:必需,但不足。 GARP(LRRC32)作为调节表型的保障作用。

获取原文
获取原文并翻译 | 示例

摘要

FOXP3 is essential for the development and function of regulatory CD4(+)CD25(hi) T (T(reg)) cells. However, recent evidence suggests that FOXP3 alone is not sufficient to completely explain the regulatory phenotype of these key players in autoimmunity and inflammation: after being activated, conventional human CD4(+) T cells transiently up-regulate FOXP3 without acquiring a regulatory function. Researchers have recently found that glycoprotein A repetitions predominant (GARP, or LRRC32) is a T(reg)-specific receptor that binds latent TGF-beta and dominantly controls FOXP3 and the regulatory phenotype via a positive feedback loop. This finding provides a missing link in our molecular understanding of FOXP3 in T(reg) cells. This viewpoint focuses on GARP as safeguard of FOXP3 and the regulatory phenotype.
机译:FOXP3对于调节性CD4(+)CD25(hi)T(T(reg))细胞的发育和功能至关重要。但是,最近的证据表明,仅FOXP3不足以完全解释这些关键分子在自身免疫和炎症中的调节表型:被激活后,传统的人类CD4(+)T细胞在不获得调节功能的情况下瞬时上调FOXP3。研究人员最近发现,主要的糖蛋白A重复(GARP或LRRC32)是一种T(reg)特异性受体,该受体结合潜在的TGF-beta,并通过正反馈回路主要控制FOXP3和调节表型。这一发现为我们对T(reg)细胞中FOXP3的分子理解提供了一个缺失的环节。这种观点集中在GARP作为FOXP3的保障和调节表型上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号